Free Trial

INSPECS Group (LON:SPEC) Stock Price Down 0.9% - Should You Sell?

INSPECS Group logo with Medical background

INSPECS Group plc (LON:SPEC - Get Free Report) shares fell 0.9% during trading on Tuesday . The stock traded as low as GBX 55.04 ($0.71) and last traded at GBX 56 ($0.73). 24,740 shares changed hands during mid-day trading, a decline of 92% from the average session volume of 305,062 shares. The stock had previously closed at GBX 56.50 ($0.73).

INSPECS Group Stock Down 0.9 %

The stock has a market cap of £56.94 million, a P/E ratio of -18.24 and a beta of 2.22. The company has a current ratio of 1.46, a quick ratio of 0.89 and a debt-to-equity ratio of 60.51. The firm's fifty day moving average is GBX 53.73 and its 200 day moving average is GBX 56.86.

INSPECS Group Company Profile

(Get Free Report)

INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products worldwide. The company offers its products under the JOSEPH, CAT, Viktor & Rolf, Hype, Henri Lloyd, Barbour, Liberty, O'Neill, Lyle & Scott, SUPERDRY, RADLEY LONDON, Temperly London, TED BAKER LONDON, MINI, L.A.M.B., Barbour International, Marc O'Polo, TALBOT RUNHOF Eyewear, BUFFALO David Bitton, Free Country, BOTANIQ, SAVILE ROW Titanium, SAVILE ROW, BRENDEL Eyewear, FREIGEIST, HUMPHREY'S eyewear, JOS ESCHENBACH, and TITANFLEX brands through optical and retail outlets.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in INSPECS Group right now?

Before you consider INSPECS Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and INSPECS Group wasn't on the list.

While INSPECS Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines